812P - Health-related quality of life (HRQL) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with cabazitaxel (CBZ) in a prospective observational study (CAPRISTANA)

Autor: Pichler, A., Barnes, G., Katolicka, J., Korunkova, H., Tomova, A., Ghosn, M., El Karak, F., Koroleva, I., Makdessi, J., Ozatilgan, A., Hitier, S., Carles, J.
Zdroj: In Annals of Oncology September 2017 28 Supplement 5:v281-v281
Databáze: ScienceDirect